New standards in hypertension and cardiovascular risk management: focus on telmisartan
Domenico Galzerano1, Cristina Capogrosso4, Sara Di Michele2, Antonio Galzerano1, Paola Paparello1, Diana Lama3, Carlo Gaudio21Department of Cardiology, San Gennaro Hospital, Naples, Italy; 2Department of Heart and Great Vessels, A. Reale, La Sapienza University, Rome, Italy; 3V Division of Internal...
Main Authors: | Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/new-standards-in-hypertension-and-cardiovascular-risk-management-focus-a4037 |
Similar Items
-
Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection
by: Domenico Galzerano, et al.
Published: (2010-06-01) -
Treatment of hypertension in obese patients: focus on telmisartan
by: I. E. Deneka, et al.
Published: (2018-12-01) -
TELMISARTAN IN CARDIOVASCULAR RISK REDUCTION
by: О. D. Ostroumova, et al.
Published: (2018-02-01) -
A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients
by: Domenico Galzerano, et al.
Published: (2012-12-01) -
THE EFFECTS NEUROPROTECTION OF TELMISARTAN ON STROKE WITH HYPERTENSION
by: ErnawatI, Iin, et al.
Published: (2020-01-01)